Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade.

Higher Gleason grade is associated with prostate cancer mortality; however, there is significant heterogeneity in this association. We evaluated whether vessel morphology, a biomarker of angiogenesis, aided in distinguishing mortality risks among men with high Gleason grading.

We characterized vessel morphology (area and irregularity) among 511 patients diagnosed with prostate cancer during 1986 to 2000, re-reviewed Gleason grade, and followed men through 2012. Men were grouped according to integrated vessel lumen irregularity and vessel area across Gleason grade. The more angiogenic group was identified as those with more irregular vessel lumen and smaller vessel area. Crude rates (95 % confidence intervals) and survival probability were estimated across Gleason grade and vessel morphology.

During a median 14-year follow-up, 62 men developed bone metastases or died of prostate cancer. Lethality rates were uniformly low within Gleason grade categories 6 and 7(3 + 4), regardless of vessel morphology. However, among men with Gleason grades of 7(4 + 3) or 8-10, the more angiogenic group was associated with fourfold higher risk of lethal outcomes compared to those with less angiogenic potential. Ten-year survival probability ranged from 95 to 74 % according to the extent of vessel morphology (p < 0.0001, log-rank test).

Vessel morphology may aid Gleason grading in predicting prostate cancer mortality risks among men diagnosed with high-grade Gleason cancers.

Cancer causes & control : CCC. 2016 Jul 05 [Epub ahead of print]

Meng Yang, Ke Zu, Lorelei A Mucci, Jennifer R Rider, Michelangelo Fiorentino, Steven K Clinton, Massimo Loda, Meir J Stampfer, Edward Giovannucci

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. ., Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., The Division of Medical Oncology, The Department of Internal Medicine, The Ohio State University, Columbus, OH, 43210, USA., Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA., Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe